Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00656305 · OUTCOME

Number of Participants With a Change in Medication Use

ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain · Source last updated 2020-02-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
3 months post treatment

What was measured

Medication Use change reported from baseline until of study. Medication use is quantified by "morphine equivalent usage" (measured separately from Responder/Non-responder definition for the primary endpoint)

Analysis population: Only 26 of the 81 subjects in ExAblate treatment arm and 6 of 26 in the sham arm were taking non-opioid medication at baseline.

Groups in this outcome

ExAblate Treatment Arm

ExAblate 2000: MR guided focused ultrasound

ExAblate Sham Control Arm

ExAblate 2000: MR guided focused ultrasound sham

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
ExAblate Treatment Arm26
ExAblate Sham Control Arm6

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
ExAblate Treatment Arm15Not reportedNot reportedNot reportedNot reported
ExAblate Sham Control Arm2Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        15
      2. group Id
        OG001
        value
        2
denoms
  1. counts
    1. group Id
      OG000
      value
      26
    2. group Id
      OG001
      value
      6
    units
    Participants
description
Medication Use change reported from baseline until of study. Medication use is quantified by "morphine equivalent usage" (measured separately from Responder/Non-responder definition for the primary endpoint)
groups
  1. description
    ExAblate 2000: MR guided focused ultrasound
    id
    OG000
    title
    ExAblate Treatment Arm
  2. description
    ExAblate 2000: MR guided focused ultrasound sham
    id
    OG001
    title
    ExAblate Sham Control Arm
param Type
COUNT_OF_PARTICIPANTS
population Description
Only 26 of the 81 subjects in ExAblate treatment arm and 6 of 26 in the sham arm were taking non-opioid medication at baseline.
reporting Status
POSTED
time Frame
3 months post treatment
title
Number of Participants With a Change in Medication Use
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice